FIA
HELP

FNY Investment Advisers’s Helus Pharma Inc. Common Stock HELP Stock Holding History

FNY Investment Advisers’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
100
– – ﹤0.01% 903
2026
Q1 		$0 Hold
100
– – ﹤0.01% 844
2025
Q4 		$0 Sell
100
-50,844
-100% -$327K ﹤0.01% 1036
2025
Q3 		$300K Buy
50,944
+50,844
+50,844% +$360K 0.1% 218
2025
Q2 		$0 Hold
100
– – ﹤0.01% 1002
2025
Q1 		$0 Buy
100
+61
+156% +$528 ﹤0.01% 771
2024
Q4 		$0 Hold
39
– – ﹤0.01% 708
2024
Q3 		$0 Sell
39
-10,991
-100% -$109K ﹤0.01% 701
2024
Q2 		$113K Buy
11,030
+2,846
+35% +$37.3K 0.08% 166
2024
Q1 		$128K Sell
8,184
-2,395
-23% -$34.6K 0.08% 165
2023
Q4 		$164K Buy
10,579
+10,526
+19,860% +$196K 0.18% 101
2023
Q3 		$1K Sell
53
-3,631
-99% -$53.5K ﹤0.01% 555
2023
Q2 		$52K Buy
+3,684
New +$44.3K 0.07% 156
2022
Q3 		– Sell
-58
Closed -$1K – 684
2022
Q2 		$1K Sell
58
-1,521
-96% -$36.9K ﹤0.01% 615
2022
Q1 		$49K Sell
1,579
-655
-29% -$23.9K 0.05% 248
2021
Q4 		$101K Buy
2,234
+1,971
+749% +$125K 0.05% 207
2021
Q3 		$21K Buy
+263
New +$23K 0.01% 481

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

FNY Investment Advisers's HELP Position: Q2 2026 in Review

FNY Investment Advisers held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2026 at 100 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #903.

FNY Investment Advisers first reported a position in HELP in Q3 2021 and has held it in 17 quarters since. The position peaked at $300K in Q3 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • FNY Investment Advisers held 100 shares of Helus Pharma Inc. Common Stock worth $0 as of Q2 2026.
  • FNY Investment Advisers left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #903 holding.
  • FNY Investment Advisers first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and has held it in 17 quarters since.
  • FNY Investment Advisers's Helus Pharma Inc. Common Stock position peaked at $300K in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.